Contribute Try STAT+ Today

For the second time this year, California officials have delayed a much-ballyhooed effort to start a program in which the state would negotiate prescription drug prices and create a its own purchasing system for certain medicines. But this time, it is unclear when the initiative will get off the ground.

A notice on the California Department of Health Care Services website says the new Medi-Cal Rx program was scheduled to start on April 1, but has been delayed. No start date was given and a department spokesperson wrote us that an update will be provided next month. The website indicates a meeting is scheduled for May 19.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • May one observe that “draft version of long list” is a bit of … understatement? The target pdf is over 200 pages. Dream Big … or “California Dreaming” as they say?

Comments are closed.